By examining a larger patient population and building on the earlier research, this new study pinpoints the precise severe forms of carotid artery disease and heart disease that resulted in the subretinal drusenoid deposits (SDD) of age-related macular degeneration (AMD).
Regular use of drugs to lower cholesterol and control type 2 diabetes may lessen the risk of the degenerative eye disease associated with ageing, known as AMD, finds a pooled data analysis of the available evidence, published online in the British Journal of Ophthalmology.
Smoking significantly increases the risk of developing severe eye conditions like cataracts, glaucoma, age-related macular degeneration (AMD) and diabetic retinopathy which can ultimately lead to vision loss if proper precautions are not taken on time. Additionally, cigarette smoke can cause puffiness below the eyes and eyelid disorders, such as inflammation and irritation.
The primary factors leading to vision issues among the population are Diabetic retinopathy (DR) and age-related macular degeneration (AMD) including cataracts.
Age-related macular degeneration (AMD), which accounts for 8.7 per cent of all blindness worldwide, is the most common cause of anxiety, and depression seen among people older than 60 years, health experts said on Monday.
Macushield tablets assist with age-related macular degeneration, diabetic retinopathy and improves overall vision
Increased screen time during the Covid-19 pandemic has led to a sharp rise in incidence of eye strain and dryness-related issues across all age groups, Dr JS Titiyal, chief of the Rajendra Prasad Centre for Ophthalmic Sciences at AIIMS, said while addressing a seminar organised in Delhi
Age-related macular degeneration is the leading cause of vision loss among people over 50.
Retinal diseases are the leading cause of preventable blindness. Lack of awareness about symptoms, ignorance and not seeking timely diagnosis and treatment, has led to a significant rise in patients suffering from vision loss, say experts.
Get updates on your preferred social platform
Follow us for the latest news, insider access to events and more.
